FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4253174593> ?p ?o ?g. }

• W4253174593 endingPage "34" @default.
• W4253174593 startingPage "28" @default.
• W4253174593 abstract "Increasing evidence that non-small cell lung cancer is a systemic disease from the outset confirms the rationale for adjuvant chemotherapy. However, clinical trial evidence of benefit is still awaited. The position is clearer in the case of neoadjuvant therapy because long-term follow up of two trials now shows that patients randomized to chemotherapy before surgery were significantly more likely to survive to 5 years than patients treated with surgery alone. Early data suggest that neoadjuvant chemotherapy based on docetaxel (Taxotere; Aventis, Antony, France) (possibly used sequentially with other agents) may be as effective as older regimens and better tolerated. Because p53 status influences the expression of microtubule-associated proteins and hence the sensitivity of a tumor to taxanes, it is possible that molecular markers could be used to customize chemotherapy to individual patients. Generally, it is becoming clearer that molecular staging is a more sensitive means of demonstrating tumor dissemination than light microscopy. The Cancer and Leukemia Group B is undertaking a prospective study using reverse transcriptase-polymerase chain reaction to detect MUC-I RNA in bone marrow and hilar and mediastinal lymph nodes removed at resection with the aim of distinguishing between stage I patients likely to remain disease-free for long periods and those at high risk of relapse. A study of small cell lung cancer is using automated fluorescence microscopy to detect keratin-positive cells in the marrow and blood of patients who have a complete response to initial therapy but are nevertheless at high overall risk of relapse. The identification of genetic lesions in a high proportion of patients with non-small cell lung cancer may guide the development of new therapies aimed at increasing rates of apoptosis among tumor cells." @default.
• W4253174593 created "2022-05-12" @default.
• W4253174593 creator A5016620187 @default.
• W4253174593 creator A5021148471 @default.
• W4253174593 creator A5044887899 @default.
• W4253174593 date "2001-02-01" @default.
• W4253174593 modified "2023-10-17" @default.
• W4253174593 title "Advances in the treatment of non-small cell lung cancer: Molecular markers take the stage" @default.
• W4253174593 cites W1603672218 @default.
• W4253174593 cites W1972362650 @default.
• W4253174593 cites W1981562535 @default.
• W4253174593 cites W2009219057 @default.
• W4253174593 cites W2052704782 @default.
• W4253174593 cites W2055210271 @default.
• W4253174593 cites W2057946421 @default.
• W4253174593 cites W2058672020 @default.
• W4253174593 cites W2059220096 @default.
• W4253174593 cites W2110495958 @default.
• W4253174593 cites W2129834876 @default.
• W4253174593 cites W2141393790 @default.
• W4253174593 cites W2170837718 @default.
• W4253174593 cites W2281741938 @default.
• W4253174593 cites W2322965840 @default.
• W4253174593 cites W2418447573 @default.
• W4253174593 cites W4239714259 @default.
• W4253174593 cites W4249473536 @default.
• W4253174593 doi "https://doi.org/10.1016/s0093-7754(01)90204-0" @default.
• W4253174593 hasPublicationYear "2001" @default.
• W4253174593 type Work @default.
• W4253174593 citedByCount "1" @default.
• W4253174593 crossrefType "journal-article" @default.
• W4253174593 hasAuthorship W4253174593A5016620187 @default.
• W4253174593 hasAuthorship W4253174593A5021148471 @default.
• W4253174593 hasAuthorship W4253174593A5044887899 @default.
• W4253174593 hasConcept C121608353 @default.
• W4253174593 hasConcept C126322002 @default.
• W4253174593 hasConcept C142724271 @default.
• W4253174593 hasConcept C143998085 @default.
• W4253174593 hasConcept C146357865 @default.
• W4253174593 hasConcept C151730666 @default.
• W4253174593 hasConcept C2776256026 @default.
• W4253174593 hasConcept C2776694085 @default.
• W4253174593 hasConcept C2778292576 @default.
• W4253174593 hasConcept C2779134260 @default.
• W4253174593 hasConcept C2780007613 @default.
• W4253174593 hasConcept C2781190966 @default.
• W4253174593 hasConcept C530470458 @default.
• W4253174593 hasConcept C71924100 @default.
• W4253174593 hasConcept C86803240 @default.
• W4253174593 hasConceptScore W4253174593C121608353 @default.
• W4253174593 hasConceptScore W4253174593C126322002 @default.
• W4253174593 hasConceptScore W4253174593C142724271 @default.
• W4253174593 hasConceptScore W4253174593C143998085 @default.
• W4253174593 hasConceptScore W4253174593C146357865 @default.
• W4253174593 hasConceptScore W4253174593C151730666 @default.
• W4253174593 hasConceptScore W4253174593C2776256026 @default.
• W4253174593 hasConceptScore W4253174593C2776694085 @default.
• W4253174593 hasConceptScore W4253174593C2778292576 @default.
• W4253174593 hasConceptScore W4253174593C2779134260 @default.
• W4253174593 hasConceptScore W4253174593C2780007613 @default.
• W4253174593 hasConceptScore W4253174593C2781190966 @default.
• W4253174593 hasConceptScore W4253174593C530470458 @default.
• W4253174593 hasConceptScore W4253174593C71924100 @default.
• W4253174593 hasConceptScore W4253174593C86803240 @default.
• W4253174593 hasLocation W42531745931 @default.
• W4253174593 hasOpenAccess W4253174593 @default.
• W4253174593 hasPrimaryLocation W42531745931 @default.
• W4253174593 hasRelatedWork W122589447 @default.
• W4253174593 hasRelatedWork W1563147852 @default.
• W4253174593 hasRelatedWork W2083483287 @default.
• W4253174593 hasRelatedWork W2172122575 @default.
• W4253174593 hasRelatedWork W2257017276 @default.
• W4253174593 hasRelatedWork W2300188460 @default.
• W4253174593 hasRelatedWork W2367501521 @default.
• W4253174593 hasRelatedWork W2407419195 @default.
• W4253174593 hasRelatedWork W3155373832 @default.
• W4253174593 hasRelatedWork W3160106878 @default.
• W4253174593 hasVolume "29" @default.
• W4253174593 isParatext "false" @default.
• W4253174593 isRetracted "false" @default.
• W4253174593 workType "article" @default.